Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

Por Ioannou, Nikolaos, Seddon, Alan M, Dalgleish, Angus, Mackintosh, David, Modjtahedi, Helmout
Publicado em 2013

Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition

Por IOANNOU, NIKOLAOS, SEDDON, ALAN M., DALGLEISH, ANGUS, MACKINTOSH, DAVID, SOLCA, FLAVIO, MODJTAHEDI, HELMOUT
Publicado no Int J Oncol (2016)

Novel Role for Matricellular Proteins in the Regulation of Islet β Cell Survival: THE EFFECT OF SPARC ON SURVIVAL, PROLIFERATION, AND SIGNALING

Por Ryall, Claire L., Viloria, Katrina, Lhaf, Fadel, Walker, Anthony J., King, Aileen, Jones, Peter, Mackintosh, David, McNeice, Rosemary, Kocher, Hemant, Flodstrom-Tullberg, Malin, Edling, Charlotte, Hill, Natasha J.
Publicado em 2014